Cipher Pharmaceuticals Inc continues to show positive momentum amidst its recent quarterly results.
This week, Cipher Pharmaceuticals Inc (CPH.TO) has seen a modest increase in its stock price, reflecting solid performance in the health care sector. The company reported its second-quarter results, which likely contributed to the current positive market sentiment surrounding the stock.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeAdvertisement
Market cap
$445.62M
P/E
10.5x
52W high
$20.56
52W low
$12.48
1W change
+4.40%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 17.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+17.5% Upside
Current Price
C$17.57
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
24.0%
Annualized
90-Day Vol
32.4%
Annualized
Trend (90d)
-9.2%
Annualized drift
90d Mean
C$17.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.38 | C$16.00 – C$18.88 |
| 60 trading days | C$17.19 | C$15.29 – C$19.33 |
| 90 trading days | C$17.00 | C$14.73 – C$19.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider Cipher Pharmaceuticals' strong fundamentals and recent performance metrics, suggesting a stable outlook for the company despite market fluctuations.
Cipher Pharmaceuticals Stock Performance
The stock has increased by 4.40% over the past week, closing at C$17.95.
Bull case
Cipher Pharmaceuticals boasts a profit margin of 60.6% and a return on equity (ROE) of 25.9%, indicating strong financial health. Analysts have set an average target of C$20.64 for the stock, suggesting potential for further growth and a moderately bullish outlook.
Bear case
With a beta of 0.46, the stock shows lower volatility compared to the broader market, which may limit rapid price movements. Investors should remain cautious of potential market fluctuations that could affect stock performance.
Recent Stock Performance
Cipher Pharmaceuticals Inc has shown a positive trend in its stock price, with a 1-day increase of 0.11% and a weekly gain of 4.40%. The stock closed at C$17.95, marking a year-to-date growth of 17.92%. This upward movement indicates steady interest from investors, particularly following the recent quarterly results.
Catalyst: Quarterly Results
Advertisement
The recent catalyst for Cipher Pharmaceuticals' stock performance stems from the company's second-quarter results reported on August 11, 2026. These results highlighted strong profitability and market positioning, likely contributing to the positive sentiment around the stock.
Technical Picture
From a technical standpoint, Cipher Pharmaceuticals is performing well above its 50-day moving average of C$16.64 and its 200-day moving average of C$15.96, indicating a strong upward trend. The stock has traded within a 52-week range of C$12.48 to C$20.56, currently resting at 68% of its range. The latest trading volume of 18,623 shares exceeded the 20-day average volume of 17,022 shares, showing increased investor interest.
Insider Activity
No recent insider activity has been reported for Cipher Pharmaceuticals, suggesting a stable management outlook and confidence in the company's ongoing performance.
Price Action Summary
Cipher Pharmaceuticals Inc closed at C$17.95, reflecting a 1-day increase of 0.11%. The stock's performance this week, alongside the positive quarterly results, positions it as a noteworthy player in the health care sector.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
